Evaluation of Clinical Outcomes of Ponto Procedures Performed in Settings Outside the Main Operating Room (i.e. Out-of-OR)
Launched by OTICON MEDICAL · Apr 8, 2025
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at the safety and outcomes of a procedure called Ponto implantation, which helps people with hearing loss. The study focuses on procedures done outside of the main operating room, in more everyday settings, to see how often complications happen when the surgery is performed this way. Researchers want to gather information from both past and current patients to get a better understanding of these procedures.
To be eligible for this study, participants must be adults aged 18 and older who have had a Ponto implant placed in an out-of-OR setting since 2019. There are no specific health conditions that would exclude someone from participating, and if you choose to join, you'll be asked to provide consent and may answer some questionnaires about your experience. Overall, this trial aims to improve the care and safety of patients receiving bone-anchored hearing aids in more accessible locations.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Adult subjects (≥18 years old) undergoing Ponto implantation in an out-of-OR setting from 2019 and onwards
- • Signed informed consent (applicable for subjects answering questionnaires)
- Exclusion Criteria:
- • No exclusion criteria have been set for this observational investigation
About Oticon Medical
Oticon Medical is a leading global innovator in the field of hearing solutions, dedicated to improving the quality of life for individuals with hearing loss. As a subsidiary of the well-established Oticon brand, Oticon Medical specializes in the development and manufacture of advanced auditory devices, including bone-anchored hearing systems and implantable solutions. Committed to research and development, the company actively sponsors clinical trials to evaluate the efficacy and safety of its products, ensuring that cutting-edge technology continues to meet the evolving needs of patients and healthcare professionals. With a focus on evidence-based practices, Oticon Medical strives to enhance auditory experiences and foster better communication for those affected by hearing impairment.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Lund, , Sweden
Lund, Skåne, Sweden
Luleå, Norrbotten, Sweden
Patients applied
Trial Officials
Dr David Morris
Principal Investigator
Queen Elizabeth II Health Sciences Centre
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported